Tissue Plasminogen Activator Market Estimated to Witness Growth Owing to Increasing Demand for Non-invasive Treatment Options
Tissue Plasminogen Activator Market Trends |
The tissue plasminogen activator market is witnessing
significant demand owing to the increasing prevalence of cardiovascular
diseases such as heart attack, deep vein thrombosis, pulmonary embolism and
stroke. Tissue plasminogen activator is a thrombolytic agent, with high fibrin
specificity, used to dissolve clots and restore blood flow in acute myocardial
infarction, ischemic stroke or massive pulmonary embolism. It provides an
effective alternative to surgery for non-invasive treatment of conditions
caused by blood clots.
The global tissue plasminogen activator
market is estimated to be valued at US$ 614.9 Mn in 2024 and is expected to
exhibit a CAGR of 5.8% over the forecast period from 2024 to 2030.
The increasing demand for minimally invasive procedures and
advantages of tissue plasminogen activator such as improved survival rates,
reduced bleeding complications and hospital stay are supporting market growth.
Key Takeaways
Key players operating in the tissue plasminogen activator market are Siemens
Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems
Corporation, Shimadzu Corporation, Hitachi, Ltd. Emerging opportunities include
development of modified variants for improving efficacy and safety profile.
Major players are focusing on geographic expansion and new product development
through collaborations and acquisitions to strengthen their market position
globally.
Key opportunities in the Tissue
Plasminogen Activator Market Trends include development of new
generation thrombolytic agents with longer duration of action and safety.
Significant increase in healthcare expenditure, infrastructure development and
disease awareness campaigns in developing regions are favoring global expansion
of the market.
Market Drivers
The global tissue plasminogen activator market is driven by the rising
geriatric population susceptible to cardiovascular diseases, increasing
prevalence of chronic diseases and the availability of favorable reimbursement
policies. Further, increasing incidence of lifestyle diseases such as diabetes
and obesity contributing to disorders caused by formation of blood clots is
expected to provide potential opportunities for tissue plasminogen activator
manufacturers over the forecast period.
PEST Analysis
Political: The regulations set by regulatory bodies like the
FDA in US and EMA in Europe regarding the approval of drugs and devices will
impact the market growth.
Economic: The growing healthcare spending coupled with increasing disposable
incomes will fuel the demand. However, higher treatment costs can restrain the Tissue
Plasminogen Activator Market to some extent.
Social: Rising instance of strokes and cardiovascular diseases worldwide is the
key driver. Growing awareness about treatment options is expanding the patient
pool.
Technological: Advancements in recombinant technology for developing improved
versions with specific mechanisms of action. Integration of imaging guidance
techniques for precision and safety during interventions.
Geographical Regions with High Market Concentration
North America region holds the major share in the global
tissue plasminogen activator market in terms of revenue, owing to developed
healthcare infrastructure, higher affordability, and growing incidence of
strokes.
Fastest Growing Region
The Asia Pacific region is anticipated to witness the
fastest growth over the forecast period owing to developing healthcare systems,
rising medical tourism, growing economy and increasing health awareness in
densely populated countries like India and China.
Get More
Insights on- Tissue
Plasminogen Activator Market
About
Author:
Ravina
Pandya, Content Writer,
has a strong foothold in the market research industry. She specializes in
writing well-researched articles from different industries, including food and
beverages, information and technology, healthcare, chemical and materials, etc.
(https://www.linkedin.com/in/ravina-pandya-1a3984191)
Comments
Post a Comment